France vs Latvia: Coverage of the human papillomavirus vaccine
France
51
in 2025
Latvia
54
in 2025
France rank
62nd
Latvia rank
60th
Coverage of the human papillomavirus vaccine over time
- France
- Latvia
How they compare
Latvia currently reports 54 against 51 in France, a difference of 3.
That makes Latvia's figure about 1.1 times France's.
The two have swapped places 4 times across 12 shared years of data; in 2014 it was Latvia ahead.
France ranks 62nd and Latvia ranks 60th of 85 countries.
Across the 2 decades both report, France averaged higher in 1 and Latvia in 1.
Head to head by decade
| Decade | France | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 23.17 | 47.33 | 24.17 | Latvia |
| 2020s | 44.67 | 44.33 | 0.3333 | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, France or Latvia?
- Latvia, at 54 against 51 in France as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between France and Latvia?
- 3, with Latvia ahead.
- How many years of comparable data are there for France and Latvia?
- 12 years are reported by both, from 2014 to 2025.
- How do France and Latvia rank globally for coverage of the human papillomavirus vaccine?
- France ranks 62nd and Latvia ranks 60th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.